Sep 14,2021

Leon Medical Centers Partners with Health Tech Company Rimidi, Reducing A1Cs in High-Risk Cohort of Patients with Type 2 Diabetes

Leon Medical Centers today announced clinical improvements in a cohort of high-risk patients with Type 2 Diabetes due to the remote patient monitoring and clinical decision support capabilities of Rimidi, a leading clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives. Leon began using the Rimidi platform, which integrates directly with their Epic electronic health record (EHR), at the beginning of 2020. 

COLLABORATION PARTNERSHIP

#institution

#rpm

#bgm

View Analyst & Ambassador Comments
Go to original news
Sep 29,2021

Nemaura Medical Launches Beta Version of Its Metabolic Health Program

Nemaura Medical, Inc., a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces the beta launch of MiBoKo, a new metabolic health program utilizing a noninvasive glucose sensor along with an AI mobile application.

PRODUCT

#rpm

View Analyst & Ambassador Comments
Go to original news
Oct 04,2021

GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor

GraphWear, a company pursuing needle-free approaches to glucose monitoring, has closed a $20.5 million Series B round. This Series B round is a vote of confidence by investors in GraphWear’s approach: to monitor key metrics in the body, like glucose, without breaking the skin at all.

FUNDING SERIES B

#rpm

View Analyst & Ambassador Comments
Go to original news
Oct 07,2021

MSU Health Care Launches Clinician-led Remote Monitoring Services to Patients Across the State

MSU Health Care now offers remote monitoring to patients with health conditions like diabetes, hypertension, obesity, high cholesterol and heart disease through a partnership with Higi Care Everyday, powered by Assure Health. Higi Care Everyday is a digital health solution that helps patients and providers stay connected and ensures patients receive the care they need, when they need it. Participating patients will receive a free set of devices for at-home use. Credentialed clinicians will monitor their health data on an ongoing basis, reaching out regularly if their numbers indicate a potential issue.

PRODUCT

#rpm

View Analyst & Ambassador Comments
Go to original news
Oct 31,2021

Initial Clinical Experience With a Simple, Home System for Early Detection and Monitoring of Diabetic Foot Ulcers: The Foot Selfie

Diabetic foot ulcers (DFUs) are a leading cause of disability and morbidity. There is an unmet need for a simple, practical, home method to detect DFUs early and remotely monitor their healing.

CLINICAL STUDY

#rpm

View Analyst & Ambassador Comments
Go to original news
Nov 01,2021

DarioHealth Gathers Momentum in the Provider Market with Two New Contracts for Remote Patient Monitoring Services

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into contracts with two prominent regional providers in Hawaii and Georgia for its Remote Patient Monitoring (RPM) services.

#rpm

View Analyst & Ambassador Comments
Go to original news
Nov 04,2021

Pediatric Endocrinology Clinic At University Of Florida Expands Implementation Of DreaMed Technology

The clinic will begin using the Advisor Pro Decision-Support System for Type 2 Diabetes, which has recently received FDA clearance, enhancing the clinic’s offering to health care practitioners and patients.

PRODUCT

#dtx

#rpm

View Analyst & Ambassador Comments
Go to original news
Dec 21,2021

Eversense NOW Remote Monitoring App for Android Users Receives CE Mark in Europe

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced it received CE mark of the Eversense® NOW Remote Monitoring App for the Android Operating System. The Eversense NOW iOS platform has previously been approved and is currently available in Europe.

REGULATORY CE MARK

#cgm

#rpm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Apr 08,2020

ABBOTT'S FREESTYLE® LIBRE 14 DAY SYSTEM NOW AVAILABLE IN U.S. FOR HOSPITALIZED PATIENTS WITH DIABETES DURING COVID-19 PANDEMIC

Abbott (NYSE: ABT) announced today that the FreeStyle Libre 14 day system, the world's leading3 continuous glucose monitoring (CGM) technology, can now be used in the hospital setting2 during the COVID-19 pandemic, according to the U.S. Food and Drug Administration (FDA).

PRODUCT

#cgm

#rpm

View Analyst & Ambassador Comments
Go to original news
Apr 08,2020

Dexcom Continuous Glucose Monitoring Systems to be Temporarily Offered to Hospitals During COVID-19 Emergency

Dexcom announced today that due to the public health crisis of COVID-19 and the need to preserve personal protective equipment and reduce the frequency of hospital staff exposure to the coronavirus, the company is making its Dexcom G6 CGM System temporarily available for remote patient monitoring in the hospital setting. This decision was made based on feedback received from the U.S. Food and Drug Administration (FDA).

PRODUCT

#rpm

#cgm

View Analyst & Ambassador Comments
Go to original news
Subscribe to RPM